Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Mild renal disease increases major bleeding in patients with atrial fibrillation undergoing percutaneous coronary stenting. …or why clinical cardiologists and interventionalists should be friends.
Flaker G, Kumar A.
Thromb Haemost. 2012 Jan;107(1):4-5. Epub 2011 Dec 8. No abstract available.
Related citations
The relevance of P2Y(12)-receptor gene variation for the outcome of clopidogrel-treated patients undergoing elective coronary stent implantation: a clinical follow-up.
Bouman HJ, van Werkum JW, Rudež G, Hackeng CM, Leebeek FW, ten Cate H, ten Berg JM, de Maat MP.
Thromb Haemost. 2012 Jan;107(1):189-91. Epub 2011 Dec 8. No abstract available.
Mild kidney disease as a risk factor for major bleeding in patients with atrial fibrillation undergoing percutaneous coronary stenting.
Manzano-Fernández S, Cambronero F, Caro-Martínez C, Hurtado-Martínez JA, Marín F, Pastor-Pérez FJ, Mateo-Martínez A, Sánchez-Martínez M, Pinar-Bermúdez E, Valdés M.
Thromb Haemost. 2012 Jan;107(1):51-8. Epub 2011 Nov 10.
Prognostic importance of preoperative anti-PF4/heparin antibodies in patients undergoing cardiac surgery. A systematic review.
Yusuf AM, Warkentin TE, Arsenault KA, Whitlock R, Eikelboom JW.
Thromb Haemost. 2012 Jan;107(1):8-14. Epub 2011 Nov 10. Review.
Evaluating the role for the optical density in the diagnosis of heparin-induced thrombocytopenia following cardiac surgery.
Chan CM, Corso PJ, Sun X, Hill PC, Shorr AF.
Thromb Haemost. 2011 Nov;106(5):934-8. Epub 2011 Sep 22.
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: similarities and dissimilarities between North America and Europe.
Huber K, Airaksinen KJ, Cuisset T, Marín F, Rubboli A, Lip GY.
Thromb Haemost. 2011 Oct;106(4):569-71. Epub 2011 Sep 12. No abstract available.
Clopidogrel response variability and the advent of personalised antiplatelet therapy. A bench to bedside journey.
Gurbel PA, Tantry US.
Thromb Haemost. 2011 Aug;106(2):265-71. Epub 2011 Jun 28. Review.
Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective.
Faxon DP, Eikelboom JW, Berger PB, Holmes DR, Bhatt DL, Moliterno DJ, Becker RC, Angiolillo DJ.
Thromb Haemost. 2011 Oct;106(4):572-84. Epub 2011 Jul 25.
Massive thrombus burden with recurrence of intracoronary thrombosis early after stenting and delayed onset of prasugrel action in a patient with ST-elevation myocardial infarction and cardiac shock.
Orban M, Byrne RA, Hausleiter J, Laugwitz KL, Sibbing D.
Thromb Haemost. 2011 Sep;106(3):555-8. Epub 2011 Jul 4. No abstract available.
The relationship between platelet reactivity and infarct-related artery patency in patients presenting with a ST-elevation myocardial infarction.
Breet NJ, van Werkum JW, Bouman HJ, Kelder JC, Hackeng CM, ten Berg JM.
Thromb Haemost. 2011 Aug;106(2):331-6. Epub 2011 Jun 28.
The in vitro effect of the new antithrombotic drug candidate ALX-0081 on blood samples of patients undergoing percutaneous coronary intervention.
van Loon JE, de Jaegere PP, Ulrichts H, van Vliet HH, de Maat MP, de Groot PG, Simoons ML, Leebeek FW.
Thromb Haemost. 2011 Jul;106(1):165-71. Epub 2011 Jun 9.
Multiple electrode aggregometry and vasodilator stimulated phosphoprotein-phosphorylation assay in clinical routine for prediction of postprocedural major adverse cardiovascular events.
Freynhofer MK, Brozovic I, Bruno V, Farhan S, Vogel B, Jakl G, Willheim M, Hübl W, Wojta J, Huber K.
Thromb Haemost. 2011 Aug;106(2):230-9. Epub 2011 May 26.
A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.
Meijer K, Kim YK, Carter D, Schulman S.
Thromb Haemost. 2011 Feb;105(2):232-8. Epub 2010 Dec 21.
Clopidogrel withdrawal: is there a "rebound" phenomenon?
Sambu N, Warner T, Curzen N.
Thromb Haemost. 2011 Feb;105(2):211-20. Epub 2010 Nov 23. Review.
Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment.
Bernlochner I, Steinhubl S, Braun S, Morath T, Jaitner J, Stegherr J, Mehilli J, von Beckerath N, Schömig A, Kastrati A, Sibbing D.
Thromb Haemost. 2010 Dec;104(6):1193-200. Epub 2010 Sep 13.
Target vessel reopening by guidewire insertion in ST-elevation myocardial infarction is a predictor of final TIMI flow and survival.
Adlbrecht C, Distelmaier K, Gündüz D, Redwan B, Plass C, Bonderman D, Kaider A, Christ G, Lang IM.
Thromb Haemost. 2011 Jan;105(1):52-8. Epub 2010 Nov 23.
Enhanced platelet inhibition by adjunctive cilostazol to dual antiplatelet therapy after drug-eluting stent implantation for complex lesions.
Jeong YH, Park Y, Kim IS, Yun SE, Kang MK, Hwang SJ, Kwak CH, Hwang JY.
Thromb Haemost. 2010 Dec;104(6):1286-9. Epub 2010 Sep 13. No abstract available.
Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients.
Kaireviciute D, Blann AD, Balakrishnan B, Lane DA, Patel JV, Uzdavinys G, Norkunas G, Kalinauskas G, Sirvydis V, Aidietis A, Lip GY.
Thromb Haemost. 2010 Jul;104(1):122-7. Epub 2010 May 10.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on